Go Pro
→ Here’s the stock symbol I’ve promised (From Stansberry Research) (Ad)tc pixel Free VERA Stock Alerts

Vera Therapeutics (VERA) Earnings Date, Estimates & Call Transcripts

Vera Therapeutics logo
$31.34 +2.45 (+8.48%)
As of 10:44 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Vera Therapeutics Earnings Summary

Vera Therapeutics announced Q2 2026 earnings on August 10, 2026, reporting an EPS of -$1.52, which topped the consensus estimate of -$1.58 by $0.06. With a trailing EPS of -$5.86, Vera Therapeutics' earnings are expected to grow next year, from ($6.45) to ($4.02) per share.

Latest Q2
Earnings Date
Aug. 10Estimated
Consensus EPS
(Aug. 10)
-$1.58
Actual EPS
(Aug. 10)
-$1.52 Beat By $0.06

Q2 2026 Earnings Resources

Powered by Quartr
Get Vera Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vera Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

VERA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Vera Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$1.35-$1.26-$1.31
Q2 20262-$1.70-$1.31-$1.51
Q3 20262-$1.64-$1.38-$1.51
Q4 20262-$1.66-$1.13-$1.40
FY 2026 8 -$6.35 -$5.08 -$5.72
Q1 20271-$1.51-$1.51-$1.51
Q2 20271-$1.35-$1.35-$1.35
Q3 20271-$0.98-$0.98-$0.98
Q4 20271-$0.54-$0.54-$0.54

Vera Therapeutics Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/10/2026Q2 2026-$1.58-$1.52+$0.06-$1.52$1.28M-
5/7/2026Q1 2026-$1.3284-$1.69 -$0.3616-$1.69$0.43M-
2/26/2026Q4 2025-$1.34-$1.39 -$0.05-$1.39--
11/5/2025Q3 2025-$1.20-$1.26 -$0.06-$1.26--
8/5/2025Q2 2025-$0.82-$1.20 -$0.38-$1.20--
5/8/2025Q1 2025-$0.75-$0.81 -$0.06-$0.81--
2/26/2025Q4 2024-$0.83-$0.72+$0.11-$0.72--
11/7/2024Q3 2024-$0.64-$0.85 -$0.21-$0.85--

Vera Therapeutics Earnings - Frequently Asked Questions

Vera Therapeutics (NASDAQ:VERA) last announced its quarterly earning data on Monday, August 10, 2026. Learn more on VERA's earnings history.

In the previous quarter, Vera Therapeutics (NASDAQ:VERA) reported ($1.52) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.58) by $0.06. Learn more on analysts' earnings estimate vs. VERA's actual earnings.

Vera Therapeutics (NASDAQ:VERA) has a recorded net income of -$299.61 million. VERA has generated -$5.86 earnings per share over the last four quarters.

Vera Therapeutics' earnings are expected to grow from ($6.45) per share to ($4.02) per share in the next year.

Related Companies
Earnings Tools

Earnings data for NASDAQ:VERA is sourced from Fiscal.ai, with the most recent quarter reported on 8/10/2026. New results are added as companies report their earnings.
From Our Partners
The options guide that actually starts at the beginning
Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...
Base Camp Trading | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...
Banyan Hill Publishing | Sponsoredtc pixel
Wall Street is staring at the wrong AI trade
Anthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...
The Oxford Club | Sponsoredtc pixel
Why I'm sending this one to my own family
Behind the Markets editor Kelly Maguire says she has never sent an email quite like this one. A sealed congres...
Behind the Markets | Sponsoredtc pixel